Allworth Financial’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.9K Buy
475
+139
+41% +$5.6K ﹤0.01% 3115
2026
Q1
$11.1K Buy
336
+4
+1% +$130 ﹤0.01% 3431
2025
Q4
$10.9K Hold
332
﹤0.01% 3216
2025
Q3
$5.92K Sell
332
-242
-42% -$3.51K ﹤0.01% 3457
2025
Q2
$6.23K Buy
574
+79
+16% +$1.03K ﹤0.01% 3145
2025
Q1
$8K Hold
495
﹤0.01% 2527
2024
Q4
$9.35K Buy
495
+245
+98% +$3.47K ﹤0.01% 2465
2024
Q3
$3.5K Hold
250
﹤0.01% 2724
2024
Q2
$2.28K Hold
250
﹤0.01% 2864
2024
Q1
$2.02K Buy
+250
New +$2.24K ﹤0.01% 2805
2022
Q1
Sell
-3,060
Closed -$29K 2106
2021
Q4
$29K Hold
3,060
﹤0.01% 981
2021
Q3
$48K Buy
+3,060
New +$54.9K ﹤0.01% 790

Other funds holding AXGN

Allworth Financial's AXGN Position: Q2 2026 in Review

Allworth Financial increased its Axogen (AXGN) stake by 41% in Q2 2026, buying an estimated $5.6K and bringing the position to 475 shares worth $21.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3115.

Allworth Financial first reported a position in AXGN in Q3 2021 and has held it in 12 quarters since. The position peaked at $48K in Q3 2021. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Allworth Financial held 475 shares of Axogen worth $21.9K as of Q2 2026.
  • Allworth Financial bought 139 Axogen shares in Q2 2026, an estimated $5.6K.
  • Axogen made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #3115 holding.
  • Allworth Financial first reported a position in Axogen in Q3 2021 and has held it in 12 quarters since.
  • Allworth Financial's Axogen position peaked at $48K in Q3 2021.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.